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journa l homepage : www.e lsev ie r . com/ loca te / rmedLETTER TO THE EDITORResponse to S. Ebihara ‘‘Cough and transdermal
long-acting b2 agonist in Japan’’Dear Editor,
We reported on adherence to tulobuterol patch used as
a controller for patients with asthma and chronic obstruc-
tive pulmonary disease (COPD). We did not investigate
adherence to this patch in short-term treatment of acute
bronchitis and common cold in our questionnaire survey,
and would not try to convince people to use tulobuterol
patch as anti-tussive medication in general through our
paper.
In Japan, tulobuterol patch is indicated for relief of
symptoms of bronchial asthma, chronic bronchitis, emphy-
sema, and acute bronchitis. But no objective data are
available on the use of the patch for acute bronchitis.
Ebihara et al. noted that tulobuterol patch is commonly
used for the treatment of acute bronchitis and common
cold without sufficient evidence.
Although there is serious concern that the increase of
mortality in asthmatic patients might be caused, at least in
part, by regular inhalation of short-acting b-agonists1 and
regular inhalation of long-acting b-agonists,2 it is unlikely
that tulobuterol patch has such a serious adverse effect
in patients receiving it for a short period of time for the
treatment of acute bronchitis and common cold. The safety0954-6111/$ - see front matter ª 2008 Elsevier Ltd. All rights reserved
doi:10.1016/j.rmed.2008.06.023is a theme that should be objectively clarified by a clinical
research.
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